'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. White House responds to Pope Leo’s rebuke of Trump peace plan for Ukraine After winning his ...

Recursion Pharmaceuticals (RXRX) stock rises after J.P. Morgan upgraded the biotech, citing a $1B+ sales potential for the ...

If only they were robotic! Instead, chatbots have developed a distinctive — and grating — voice. Credit...Illustration by Giacomo Gambineri Supported by By Sam Kriss In the quiet hum of our digital ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

The world’s energy demand is rising, and NREL’s ULIS power module could help meet it. Demand for energy worldwide is climbing rapidly, driven in part by power hungry data centers that support ...

“Paddy Power has had a hugely positive impact on the World Darts Championship over the past two years,” said PDC Chief Executive Matt Porter once the news was announced. “Their creativity, investment ...

Ramanujan’s insights into pi are now guiding scientists toward a deeper understanding of how the universe works.

The roll and write genre has exploded in recent years. This accessible style of gameplay is derived from the classic board game Yahtzee. Players roll dice or flip cards, and then use the revealed ...